TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

Phase 3

Completed

Conditions: Exercise-induced Bronchospasm

Interventions: Drug: albuterol aerosol by HFA BOI
Drug: albuterol aerosol by HFA MDI
Drug: placebo aerosol by HFA

First Posted Date: 2004-06-17

Last Posted Date: 2021-11-24

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 24

Registration Number: NCT00085774

Locations: 🇺🇸
Colorado Allergy and Asthma Centers, PC, Lakewood, Colorado, United States

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Phase 2

Completed

Conditions: Recurrent Glioblastoma Multiforme

Interventions: Drug: TP-38
Drug: TP38

First Posted Date: 2003-10-29

Last Posted Date: 2012-01-20

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 56

Registration Number: NCT00071539

Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients

Phase 4

Terminated

Conditions: Asthma

Interventions: Drug: Flovent Diskus
Drug: Qvar

First Posted Date: 2003-10-29

Last Posted Date: 2021-11-24

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 49

Registration Number: NCT00071552

Locations: 🇺🇸
National Jewish Medical and Research Center, Denver, Colorado, United States

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Phase 2

Terminated

Conditions: Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Mixed Oligoastrocytoma

Interventions: Drug: Talampanel

First Posted Date: 2003-06-12

Last Posted Date: 2011-05-23

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 30

Registration Number: NCT00062504

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Phase 2

Completed

Conditions: Asthma

Interventions: Drug: Albuterol HFA-MDI
Drug: Albuterol HFA-BOI

First Posted Date: 2003-02-17

Last Posted Date: 2021-11-30

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 14

Registration Number: NCT00054964

Locations: 🇺🇸
National Jewish Medical and Research Ceter, Denver, Colorado, United States

Effects of Talampanel on Patients With Advanced Parkinson's Disease

Phase 1

Completed

Conditions: Dyskinesias
Parkinson Disease
Movement Disorders

Interventions: Drug: talampanel

First Posted Date: 2002-05-09

Last Posted Date: 2011-04-13

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 22

Registration Number: NCT00036296

Multicenter Trial For Patients With Acute Crohn's Disease

Phase 2

Completed

Conditions: Crohn's Disease

First Posted Date: 2002-05-06

Last Posted Date: 2021-12-08

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Registration Number: NCT00035503

Locations: 🇺🇸
Richard MacDermott, Albany, New York, United States
🇺🇸
University of Chicago Hospital Medical Center, Chicago, Illinois, United States
🇺🇸
Stuart Weisman, Palo Alto, California, United States

and more 8 locations

Multicenter Trial for Adults With Partial Seizures

Phase 2

Completed

Conditions: Epilepsy

Interventions: Drug: Talampanel
Drug: Placebo

First Posted Date: 2002-05-03

Last Posted Date: 2011-03-17

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 190

Registration Number: NCT00034814

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy